MAXIDENT CLINIC LIMITED

Company Registration Number:
07607040 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2024

Period of accounts

Start date: 01 June 2023

End date: 31 May 2024

MAXIDENT CLINIC LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2024

Balance sheet
Notes

MAXIDENT CLINIC LIMITED

Balance sheet

As at 31 May 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 10,401 20,802
Tangible assets: 4 335,810 284,483
Total fixed assets: 346,211 305,285
Current assets
Stocks: 10,500 10,500
Debtors:   1,118,821 825,010
Cash at bank and in hand: 260,728 577,248
Total current assets: 1,390,049 1,412,758
Creditors: amounts falling due within one year:   (312,176) (359,570)
Net current assets (liabilities): 1,077,873 1,053,188
Total assets less current liabilities: 1,424,084 1,358,473
Provision for liabilities: (57,047) (44,063)
Total net assets (liabilities): 1,367,037 1,314,410
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 1,366,937 1,314,310
Shareholders funds: 1,367,037 1,314,410

The notes form part of these financial statements

MAXIDENT CLINIC LIMITED

Balance sheet statements

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 February 2025
and signed on behalf of the board by:

Name: M Zhaeentan
Status: Director

The notes form part of these financial statements

MAXIDENT CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MAXIDENT CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

2. Employees

2024 2023
Average number of employees during the period 18 18

MAXIDENT CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

3. Intangible Assets

Total
Cost £
At 01 June 2023 1,664,391
At 31 May 2024 1,664,391
Amortisation
At 01 June 2023 1,643,589
Charge for year 10,401
At 31 May 2024 1,653,990
Net book value
At 31 May 2024 10,401
At 31 May 2023 20,802

MAXIDENT CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

4. Tangible Assets

Total
Cost £
At 01 June 2023 491,834
Additions 83,016
At 31 May 2024 574,850
Depreciation
At 01 June 2023 207,351
Charge for year 31,689
At 31 May 2024 239,040
Net book value
At 31 May 2024 335,810
At 31 May 2023 284,483